These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 29143253)
1. Ruling out clinically significant prostate cancer with negative multi-parametric MRI. An JY; Sidana A; Holzman SA; Baiocco JA; Mehralivand S; Choyke PL; Wood BJ; Turkbey B; Pinto PA Int Urol Nephrol; 2018 Jan; 50(1):7-12. PubMed ID: 29143253 [TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065 [TBL] [Abstract][Full Text] [Related]
3. Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance. Curci NE; Lane BR; Shankar PR; Noyes SL; Moriarity AK; Kubat A; Brede C; Montgomery JS; Auffenberg GB; Miller DC; Montie JE; George AK; Davenport MS Urology; 2018 Jun; 116():137-143. PubMed ID: 29653121 [TBL] [Abstract][Full Text] [Related]
4. Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary? Wang RS; Kim EH; Vetter JM; Fowler KJ; Shetty AS; Mintz AJ; Badhiwala NG; Grubb RL; Andriole GL Urology; 2017 Apr; 102():190-197. PubMed ID: 27845218 [TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy. Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233 [TBL] [Abstract][Full Text] [Related]
6. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy. Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296 [TBL] [Abstract][Full Text] [Related]
7. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients. Washino S; Okochi T; Saito K; Konishi T; Hirai M; Kobayashi Y; Miyagawa T BJU Int; 2017 Feb; 119(2):225-233. PubMed ID: 26935594 [TBL] [Abstract][Full Text] [Related]
8. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)? Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489 [TBL] [Abstract][Full Text] [Related]
9. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies. Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169 [TBL] [Abstract][Full Text] [Related]
10. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging. Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351 [TBL] [Abstract][Full Text] [Related]
11. Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification. Muthigi A; Sidana A; George AK; Kongnyuy M; Shakir N; Kadakia M; Maruf M; Frye TP; Mertan F; Su D; Merino MJ; Choyke PL; Turkbey B; Wood BJ; Pinto PA Int Urol Nephrol; 2016 Sep; 48(9):1445-52. PubMed ID: 27305918 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results. Wysock JS; Mendhiratta N; Zattoni F; Meng X; Bjurlin M; Huang WC; Lepor H; Rosenkrantz AB; Taneja SS BJU Int; 2016 Oct; 118(4):515-20. PubMed ID: 26800439 [TBL] [Abstract][Full Text] [Related]
13. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer. Otti VC; Miller C; Powell RJ; Thomas RM; McGrath JS BJU Int; 2019 Jan; 123(1):82-90. PubMed ID: 29804315 [TBL] [Abstract][Full Text] [Related]
15. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer. Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study. Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Winther MD; Jakobsen H; Thomsen HS JAMA Netw Open; 2018 Jun; 1(2):e180219. PubMed ID: 30646066 [TBL] [Abstract][Full Text] [Related]
18. Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy. Lu AJ; Syed JS; Nguyen KA; Nawaf CB; Rosoff J; Spektor M; Levi A; Humphrey PA; Weinreb JC; Schulam PG; Sprenkle PC Urology; 2017 Jul; 105():118-122. PubMed ID: 28322902 [TBL] [Abstract][Full Text] [Related]
19. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy. Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132 [No Abstract] [Full Text] [Related]
20. Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance? Pepe P; Garufi A; Priolo G; Pennisi M World J Urol; 2016 Sep; 34(9):1249-53. PubMed ID: 26699628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]